Effects of pimozide on the psychopathology of delusional disorder.

1. The effects of pimozide on the psychopathology of delusional disorder were studied. 2. After six weeks, pimozide (2-12 mg/day) administration had no effect on the Brief Psychiatric Rating Scale, or in the psychological, social and occupational functioning, as measured by the Global Assessment of Functioning Scale. 3. When the different dimensions of the delusional experience were looked upon, no modifications were observed in any of them after six weeks of pimozide treatment. 4. These data failed to support the therapeutic role of pimozide in the treatment of delusional disorder and may suggest, when compared to other disorders with prominent delusions such as schizophrenia, a different neurobiology for the illness.
AuthorsH Silva, S Jerez, A Ramirez, P Renteria, N Aravena, D Salazar, R Labarca
JournalProgress in neuro-psychopharmacology & biological psychiatry (Prog Neuropsychopharmacol Biol Psychiatry) Vol. 22 Issue 2 Pg. 331-40 (Feb 1998) ISSN: 0278-5846 [Print] ENGLAND
PMID9608605 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antipsychotic Agents
  • Pimozide
  • Adult
  • Antipsychotic Agents (pharmacology, therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pimozide (pharmacology, therapeutic use)
  • Psychiatric Status Rating Scales
  • Schizophrenia, Paranoid (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: